Boston CRO giant Parexel said it is buying biopharma functional service provider ExecuPharm for an undisclosed amount.

CROs can look forward to “steady but tentative growth” in the coming years, but the biggest gainers will be the largest companies in the business, with the…

As both healthcare data and consultancy firm IMS Health and Quintiles, the world’s largest CRO, begin the process of becoming one giant $19 billion entity, the…

Clinical study provider Biomedical Systems has formed a new collab with digital health company Foundry to be able to help pharma, biotech and CRO clients view…

Pittsburgh’s Velocity Fund Partners has picked up CRO IndiPharm for an undisclosed amount, renaming the Philadelphia firm InClinica.

inVentiv will cancel its planned IPO this summer after receiving a major investment from buyout firm Advent as it joins Thomas H. Lee Partners in having an…

Drilling deeper into its drug discovery platform, hybrid biotech-CRO Evotec has signed a deal with British charity Antibiotic Research UK to help older…

Two major academic medical centers have been given a 7-year, $26.5 million cash boost from the U.S. government to help weed out inefficiencies in clinical…

Germany’s Evotec has penned a new deal with a leading U.S. university that will see it gain access to one of the hottest tickets in drug development: CRISPR…

Partnering